Effects of sevoflurane on QT parameters in children with congenital sensorineural hearing loss

Anaesthesia

Volumn 64, Issue 1, 2009, Pages 3-8

  Kim, H S ^a   Kim, J T ^a   Kim, C S ^a   Kim, S D ^a   Kim, K ^b   Yum, M K ^c  

^a Seoul National University   (South Korea)

^b Pukyong National University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

SEVOFLURANE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT;

ACCURACY; ANESTHESIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; HUMAN; PERCEPTION DEAFNESS; QT INTERVAL; SCHOOL CHILD; SPECTROSCOPY; ADOLESCENT; ALGORITHM; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; LONG QT SYNDROME; METHODOLOGY; PATHOPHYSIOLOGY; PATIENT MONITORING; PRESCHOOL CHILD; SIGNAL PROCESSING;

ADOLESCENT; ALGORITHMS; ANESTHETICS, INHALATION; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; HEARING LOSS, SENSORINEURAL; HEART RATE; HUMANS; LONG QT SYNDROME; METHYL ETHERS; MONITORING, INTRAOPERATIVE; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 58249089870     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05678.x     Document Type: Article

References (26)

1. Loeckinger A, Kleinsasser A, Maier S, et al. Sustained prolongation of the QTc interval after anesthesia with sevoflurane in infants during the first six months of life. Anesthesiology 2003; 98: 639-42.
2. Whyte SD, Booker PD, Buckley DG. The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children. Anesthesia and Analgesia 2005; 100: 71-7.
3. Kuenszberg E, Loeckinger A, Kleinsasser A, Lindner KH, Puehringer F, Hoermann C. Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. European Journal of Anesthesiology 2000; 17: 662-4.
4. Yildirim H, Adanir T, Atay A, Katircioglu K, Savaci S. The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. European Journal of Anaesthesiology 2004; 21: 566-70.
5. Chiang C, Roden DM. The long QT syndromes: genetic basis and clinical implications. Journal of American College of Cardiology 2000; 36: 1-12.
6. Magdi H, Habbal E, Mahoney CO. QT intervals in children with sensory neural hearing loss. Pacing and Clinical Electro-physiology 2002; 25: 435-9.
7. Tuncer C, Cokkeser Y, Komsuoglu B, et al. Assessment of ventricular repolarization in deaf-mute children. Pediatric Cardiology 2000; 21: 135-40.
8. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circulation Research 1991; 68: 1729-41.
9. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998; 98: 1928-36.
10. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997; 96: 1557-65.
11. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobb DE. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. European Heart Journal 1999; 20: 278-84.
12. Medina-Ravell VA, Lankipalli RS, Yan GX, et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003; 107: 740-6.
13. Piccirillo G, Magri D, Matera S, et al. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study. European Heart Journal 2007; 28: 1344-50.
14. Mather LE, Duke CC, Ladd LA, Copeland SE, Gallagher G, Chang DH. Direct cardiac effects of coronary site-directed thiopental and its enantiomers: a comparison to propofol in conscious sheep. Anesthesiology 2004; 101: 354-64.
15. Haigney MC, Zareba W, Gentlesk PJ, et al. Multicenter automatic defibrillator implantation trial II investigators. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Journal of American College of Cardiology 2004; 44: 1481-7.
16. Piccirillo G, Quaglione R, Nocco M, et al. Effects of long-term β-blocker therapy on QT variability index in subjects with chronic heart failure. American Journal of Cardiology 2002; 90: 1113-17.
17. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: quantitative probe of beat to beat cardiovascular control. Science 1981; 213: 220-2.
18. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997; 96: 2038-47.
19. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of betaadrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998; 98: 2314-22.
20. Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. Journal of Cardiovascular Electrophysiology 1998; 9: 899-908.
21. Tutar E, Tekin M, Ucar T, Comak E, Ocal B, Atalay S. Assessment of ventricular repolarization in a large group of children with early onset deafness. Pacing and Clinical Electrophysiology 2004; 27: 1217-20.
22. Holand S, Girard A, Laude D, Meyer-Bisch C, Elghozi JL. Effects of an auditory startle on blood pressure and heart rate in humans. Journal of Hypertenssion 1999; 17: 1893-7.
23. Murakami DM, Erkman L, Hermanson O, Rosenfeld MG, Fuller CA. Evidence for vestibular regulation of autonomic functions in a mouse genetic model. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 17078-82.
24. Van Camp G, Willems PJ, Smith RJ. Nonsyndromic hearing impairment: unparalleled heterogeneity. American Journal of Human Genetics 1997; 60: 758-64.
25. Snoeckx RL, Huygen PLM, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicentric study. American Journal of Human Genetics 2005; 77: 945-57.
26. Kenneson A, Van Naarden Braun K, Boyle C. GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. Genetics in Medicine 2002; 4: 258-74.